Details for New Drug Application (NDA): 085883
✉ Email this page to a colleague
NDA 085883 describes CAPITAL AND CODEINE, which is a drug marketed by Actavis Mid Atlantic, Valeant Pharms Llc, and Carnrick, and is included in three NDAs. Additional details are available on the CAPITAL AND CODEINE profile page.
The generic ingredient in CAPITAL AND CODEINE is acetaminophen; codeine phosphate. There are sixty-six drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the acetaminophen; codeine phosphate profile page.
The generic ingredient in CAPITAL AND CODEINE is acetaminophen; codeine phosphate. There are sixty-six drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the acetaminophen; codeine phosphate profile page.
Summary for 085883
| Tradename: | CAPITAL AND CODEINE |
| Applicant: | Actavis Mid Atlantic |
| Ingredient: | acetaminophen; codeine phosphate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SUSPENSION;ORAL | Strength | 120MG/5ML;12MG/5ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
